Jones, Maura J <br/><br/>
Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment.  [electronic resource] 

 -  Journal of thrombosis and thrombolysis  Aug 2020 
 - 330-336 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1573-742X 
<br/><br/><label>Standard No.: </label>10.1007/s11239-019-02028-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Atrial Fibrillation--complications<br/>Drug Administration Schedule<br/>Factor Xa Inhibitors--administration & dosage<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Kidney--physiopathology<br/>Kidney Diseases--complications<br/>Male<br/>Middle Aged<br/>Pyrazoles--administration & dosage<br/>Pyridones--administration & dosage<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Severity of Illness Index<br/>Stroke--diagnosis<br/>Time Factors<br/>Treatment Outcome